S&P 500   3,880.30 (-2.35%)
DOW   31,401.24 (-1.50%)
QQQ   283.58 (-3.37%)
AAPL   138.18 (-3.44%)
MSFT   255.29 (-2.06%)
FB   176.59 (-10.01%)
GOOGL   2,066.05 (-7.34%)
AMZN   2,071.58 (-3.70%)
TSLA   638.49 (-5.39%)
NVDA   160.15 (-5.23%)
BABA   82.86 (-5.01%)
NIO   14.74 (-7.88%)
AMD   90.92 (-4.37%)
CGC   4.93 (-5.01%)
MU   66.60 (-4.30%)
T   20.71 (-0.14%)
GE   72.26 (-4.24%)
F   12.32 (-3.98%)
DIS   100.56 (-4.98%)
AMC   10.65 (-8.03%)
PFE   52.93 (+0.09%)
PYPL   77.52 (-4.51%)
NFLX   178.50 (-4.77%)
S&P 500   3,880.30 (-2.35%)
DOW   31,401.24 (-1.50%)
QQQ   283.58 (-3.37%)
AAPL   138.18 (-3.44%)
MSFT   255.29 (-2.06%)
FB   176.59 (-10.01%)
GOOGL   2,066.05 (-7.34%)
AMZN   2,071.58 (-3.70%)
TSLA   638.49 (-5.39%)
NVDA   160.15 (-5.23%)
BABA   82.86 (-5.01%)
NIO   14.74 (-7.88%)
AMD   90.92 (-4.37%)
CGC   4.93 (-5.01%)
MU   66.60 (-4.30%)
T   20.71 (-0.14%)
GE   72.26 (-4.24%)
F   12.32 (-3.98%)
DIS   100.56 (-4.98%)
AMC   10.65 (-8.03%)
PFE   52.93 (+0.09%)
PYPL   77.52 (-4.51%)
NFLX   178.50 (-4.77%)
S&P 500   3,880.30 (-2.35%)
DOW   31,401.24 (-1.50%)
QQQ   283.58 (-3.37%)
AAPL   138.18 (-3.44%)
MSFT   255.29 (-2.06%)
FB   176.59 (-10.01%)
GOOGL   2,066.05 (-7.34%)
AMZN   2,071.58 (-3.70%)
TSLA   638.49 (-5.39%)
NVDA   160.15 (-5.23%)
BABA   82.86 (-5.01%)
NIO   14.74 (-7.88%)
AMD   90.92 (-4.37%)
CGC   4.93 (-5.01%)
MU   66.60 (-4.30%)
T   20.71 (-0.14%)
GE   72.26 (-4.24%)
F   12.32 (-3.98%)
DIS   100.56 (-4.98%)
AMC   10.65 (-8.03%)
PFE   52.93 (+0.09%)
PYPL   77.52 (-4.51%)
NFLX   178.50 (-4.77%)
S&P 500   3,880.30 (-2.35%)
DOW   31,401.24 (-1.50%)
QQQ   283.58 (-3.37%)
AAPL   138.18 (-3.44%)
MSFT   255.29 (-2.06%)
FB   176.59 (-10.01%)
GOOGL   2,066.05 (-7.34%)
AMZN   2,071.58 (-3.70%)
TSLA   638.49 (-5.39%)
NVDA   160.15 (-5.23%)
BABA   82.86 (-5.01%)
NIO   14.74 (-7.88%)
AMD   90.92 (-4.37%)
CGC   4.93 (-5.01%)
MU   66.60 (-4.30%)
T   20.71 (-0.14%)
GE   72.26 (-4.24%)
F   12.32 (-3.98%)
DIS   100.56 (-4.98%)
AMC   10.65 (-8.03%)
PFE   52.93 (+0.09%)
PYPL   77.52 (-4.51%)
NFLX   178.50 (-4.77%)
LON:JMAT

Johnson Matthey (JMAT) Share Forecast, Price & News

GBX 2,300
-4.00 (-0.17%)
(As of 05/24/2022 04:09 PM ET)
Add
Compare
Today's Range
2,264
2,318
50-Day Range
1,811.50
2,360
52-Week Range
1,650
3,252
Volume
4.80 million shs
Average Volume
1.04 million shs
Market Capitalization
£4.23 billion
P/E Ratio
29.08
Dividend Yield
3.05%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive JMAT News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson Matthey and its competitors with MarketBeat's FREE daily newsletter.

Johnson Matthey logo

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
£17.28 billion
Cash Flow
GBX 378.53 per share
Book Value
GBX 1,386.20 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£4.23 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
6/11/2020
Today
5/24/2022
Next Earnings (Estimated)
5/26/2022

MarketRank

Overall MarketRank

1.71 out of 5 stars

Analyst Opinion: 1.1Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -













Johnson Matthey (LON:JMAT) Frequently Asked Questions

Is Johnson Matthey a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Johnson Matthey in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Johnson Matthey stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JMAT, but not buy additional shares or sell existing shares.
View analyst ratings for Johnson Matthey
or view top-rated stocks.

When is Johnson Matthey's next earnings date?

Johnson Matthey is scheduled to release its next quarterly earnings announcement on Thursday, May 26th 2022.
View our earnings forecast for Johnson Matthey
.

How were Johnson Matthey's earnings last quarter?

Johnson Matthey PLC (LON:JMAT) posted its quarterly earnings data on Thursday, June, 11th. The company reported $199.20 EPS for the quarter, topping the consensus estimate of $197.10 by $2.10.
View Johnson Matthey's earnings history
.

How often does Johnson Matthey pay dividends? What is the dividend yield for Johnson Matthey?

Johnson Matthey announced a dividend on Wednesday, November 24th. Shareholders of record on Thursday, December 2nd will be given a dividend of GBX 22 per share on Tuesday, February 1st. This represents a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, December 2nd. The official announcement can be accessed at this link.
View Johnson Matthey's dividend history
.

Is Johnson Matthey a good dividend stock?

Johnson Matthey pays an annual dividend of GBX 0.70 per share and currently has a dividend yield of 3.05%. The dividend payout ratio of Johnson Matthey is 0.88%. This payout ratio is at a healthy, sustainable level, below 75%.
View Johnson Matthey's dividend history.

What price target have analysts set for JMAT?

6 Wall Street analysts have issued 12 month price objectives for Johnson Matthey's stock. Their forecasts range from GBX 2,000 to GBX 2,600. On average, they anticipate Johnson Matthey's share price to reach GBX 2,300 in the next year.
View analysts' price targets for Johnson Matthey
or view top-rated stocks among Wall Street analysts.

Who are Johnson Matthey's key executives?
Johnson Matthey's management team includes the following people:
  • Mr. Robert J. MacLeod, Chief Exec. & Exec. Director (Age 54)
  • Ms. Anna Manz, CFO & Exec. Director (Age 45)
  • Mr. John F. Walker, Exec. Director of Emission Control Technologies & Exec. Director
  • Mr. Alan E. Nelson, Chief Technology Officer and Division Director of New Bus.es
  • Mr. Simon Farrant, Gen. Counsel & Company Sec.
What other stocks do shareholders of Johnson Matthey own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson Matthey investors own include Lloyds Banking Group (LLOY), Barclays (BARC), Experian (EXPN), Aviva (AV), GlaxoSmithKline (GSK), Imperial Brands (IMB), National Grid (NG), Reckitt Benckiser Group (RB), Unilever (ULVR) and Anglo American (AAL).

What is Johnson Matthey's stock symbol?

Johnson Matthey trades on the London Stock Exchange (LON) under the ticker symbol "JMAT."

How do I buy shares of Johnson Matthey?

Shares of JMAT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Johnson Matthey's stock price today?

One share of JMAT stock can currently be purchased for approximately GBX 2,300.

How much money does Johnson Matthey make?

Johnson Matthey has a market capitalization of £4.23 billion and generates £17.28 billion in revenue each year.

What is Johnson Matthey's official website?

The official website for Johnson Matthey is www.matthey.com.

How can I contact Johnson Matthey?

Johnson Matthey's mailing address is 5th Fl, 25 Farringdon Street, LONDON, EC4A 4AB, United Kingdom. The company can be reached via phone at +44-20-72698400.

This page was last updated on 5/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.